Tong Ren Tang Technologies Co. Ltd. Non-GAAP EPS of C$0.43, Revenue of C$23.89M
Kenbei Miao (02161.HK) cancelled 3.662 million shares and repurchased shares on February 27
On February 27, Gelonghui | Jianbei Miaomiao (02161.HK) issued an announcement to cancel 3.662 million shares purchased on February 27, 2024.
E-Home Household Services Subsidiary Provides Business Plan and Partners With Traditional Chinese Medicine Company
Express News | National Health Commission: carry out TCM intervention activities in adolescent myopia, obesity and scoliosis
China Resources Pharma Concludes Purchase of Controlling Stake in Boya Bio
China Healthwise Unit Divests 6 Million Shares in IDG Energy
Wai Yuen Tong Medicine Turns to Profit in Fiscal H1 on Higher Revenue; Shares Jump 4%
TOT Biopharm International Forms Pharma Sales JV With China Resources Pharmaceutical
Luye Pharma Submits Investigational New Drug Application for Parkinson's Disease Treatment to US FDA
Luye Pharma Grants Swiss Partner Exclusive Rights for Dementia Treatment in Switzerland
Wai Yuen Tong Medicine to Turn to Profit in Fiscal H1; Shares surged about 18%
China Healthwise Unit Offloads Shares in IDG Energy Investment
Shineway Pharma's January-September Revenue Rises 24%
JBM Healthcare Projects Profit Drop in Fiscal H1
Dong-E-E-Jiao Swings to Profit in January-September
Jiangzhong Pharma's January-September Profit Jumps 14%
China Resources Pharma Makes Progress on Acquisition of 30% Stake in Boya Bio
Baiyunshan Pharmaceutical's Q3 Profit Jumps 10%
China Resources Sanjiu Logs Higher Net Profit, Revenue in January-September; Shares Slump 10%
Tong Ren Tang Technologies Books Over $60 Million in January-September Profit